Synthesis and evaluation of the anti-hepatitis B virus activity of 4'-Azido-thymidine analogs and 4'-Azido-2'-deoxy-5-methylcytidine analogs: structural insights for the development of a novel anti-HBV agent.


Journal

Nucleosides, nucleotides & nucleic acids
ISSN: 1532-2335
Titre abrégé: Nucleosides Nucleotides Nucleic Acids
Pays: United States
ID NLM: 100892832

Informations de publication

Date de publication:
2020
Historique:
pubmed: 14 9 2019
medline: 15 12 2020
entrez: 14 9 2019
Statut: ppublish

Résumé

Hepatitis B virus (HBV) infection is a major worldwide health problem that requires the development of improved antiviral therapies. Here, a series of 4'-Azido-thymidine/4'-Azido-2'-deoxy-5-methylcytidine derivatives (

Identifiants

pubmed: 31514570
doi: 10.1080/15257770.2019.1664749
pmc: PMC8191380
mid: NIHMS1704115
doi:

Substances chimiques

Antiviral Agents 0
4'-azidothymidine 130108-72-4
Zidovudine 4B9XT59T7S
Cytidine 5CSZ8459RP
5-methylcytidine TL9PB228DC

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

518-529

Subventions

Organisme : Intramural NIH HHS
ID : ZIA BC011486
Pays : United States

Références

Curr Opin Pharmacol. 2005 Oct;5(5):520-8
pubmed: 16087397
AIDS. 2008 Jul 31;22(12):1399-410
pubmed: 18614862
J Med Chem. 2015 May 14;58(9):3693-703
pubmed: 25905540
J Med Chem. 2016 Oct 27;59(20):9513-9531
pubmed: 27748590
Clin Liver Dis. 2016 Nov;20(4):645-665
pubmed: 27742005
Curr Opin Virol. 2014 Oct;8:1-9
pubmed: 24814823
Antimicrob Agents Chemother. 2019 Mar 27;63(4):
pubmed: 30670420
Lancet. 2014 Dec 6;384(9959):2053-63
pubmed: 24954675
Epidemiol Rev. 2006;28:112-25
pubmed: 16754644
Hepatology. 2018 Apr;67(4):1560-1599
pubmed: 29405329
J Med Chem. 1994 Feb 18;37(4):431-8
pubmed: 8120862
Antivir Ther. 2012;17(8):1593-9
pubmed: 22910281
J Org Chem. 2016 Apr 1;81(7):2827-36
pubmed: 27009432
Cell Mol Biol (Noisy-le-grand). 2011 Feb 12;57(1):40-6
pubmed: 21366961
Hepatology. 2015 Oct;62(4):1024-36
pubmed: 26122273
Gastroenterology. 2009 Nov;137(5):1593-608.e1-2
pubmed: 19737565
JAMA. 2018 May 1;319(17):1802-1813
pubmed: 29715359
Antiviral Res. 2010 Jan;85(1):39-58
pubmed: 19887088
J Med Chem. 1992 Apr 17;35(8):1440-51
pubmed: 1573638
Hepatology. 2009 May;49(5 Suppl):S103-11
pubmed: 19399806
Nucleosides Nucleotides Nucleic Acids. 2015;34(8):590-602
pubmed: 26167667
Antimicrob Agents Chemother. 1990 Oct;34(10):1986-90
pubmed: 2291664

Auteurs

Kengo Onitsuka (K)

Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.

Ryoh Tokuda (R)

Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.

Nobuyo Kuwata-Higashi (N)

Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.

Hiroki Kumamoto (H)

Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, Saitama, Japan.

Manabu Aoki (M)

Experimental Retrovirology Section, HIV & AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Masayuki Amano (M)

Departments of Infectious Diseases and Hematology, Kumamoto University School of Medicine, Kumamoto, Japan.

Satoru Kohgo (S)

Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.

Debananda Das (D)

Experimental Retrovirology Section, HIV & AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Kazuhiro Haraguchi (K)

Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, Saitama, Japan.

Hiroaki Mitsuya (H)

Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
Experimental Retrovirology Section, HIV & AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Departments of Infectious Diseases and Hematology, Kumamoto University School of Medicine, Kumamoto, Japan.

Shuhei Imoto (S)

Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH